Register Interest
Register Interest for TCR-based Therapies for Solid Tumors Summit 2024 Below!
Registration for TCR-based Therapies for Solid Tumors Summit 2023 is now closed.
Thank you to our Speakers, Sponsors & Delegates for joining us!
Join Your Peers at the Next Meeting in the Series:
Explore Related Cell Therapy Products
Cell Therapy
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Conferences
Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.
Data
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
Networking
A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors.
Research
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.